Amgen (AMGN): analysis and statistics
Return, volatility, Sharpe ratio and risk for Amgen, an S&P 500 component in the Health Care sector. Data as of 2026-07-30.
| Last close price | $387.75 |
| Sector (GICS) | Health Care |
| Annualized return (3.0 yr) | +22.13% |
| Total return over period | +81.58% |
| Annualized volatility | 26.35% |
| Sharpe ratio | 0.70 |
| Sortino ratio | 1.07 |
| Max drawdown | -22.74% |
| CVaR 95% (avg. loss, worst 5% of days) | -3.63% |
| Correlation with the S&P 500 | 0.29 |
| Period range | $210.13 – $393.10 |
| Trading days analyzed | 752 |
Over the last 3.0 years, Amgen (AMGN) has posted an annualized return of +22.13% with annual volatility of 26.35%, a Sharpe ratio of 0.70. Its worst stretch (max drawdown from a peak) was -22.74%. Its correlation with the S&P 500 is 0.29, which means it moves fairly independently of the index, useful for diversification.
These are historical, realized metrics, not projections: they describe how the stock behaved, not how it will behave going forward. To see how AMGN would fit inside an optimized portfolio alongside other S&P 500 stocks, try the optimizer.
Optimize a portfolio with AMGN →
Other Health Care stocks
What is the Sharpe ratio? · How to optimize an S&P 500 portfolio